Lunit Inc.
Lunit Inc. utilizes Artificial Intelligence for the purpose of cancer screening and treatment, thereby saving numerous lives.
What is Lunit Inc.?
Lunit Inc. uses AI to create cutting-edge technology for cancer diagnosis and care. AI solutions from Lunit Inc. help find cancer early and forecast how well treatments work, saving many lives.
How to use Lunit Inc.?
Healthcare professionals can integrate Lunit's AI software into their existing medical imaging systems to utilize it for cancer screening. This integration enables the accurate detection of cancers at an early stage, resulting in timely medical intervention and higher survival rates. Lunit's AI biomarker can be used to predict how well a patient will respond to cancer treatment, which helps to optimize the effectiveness of immunotherapy.
Features
- Lunit Inc.'s main capabilities consist of:
Use Cases
- Combining Artificial Intelligence into everyday cancer treatment routines
- Lunit Inc. is integrating Artificial Intelligence in Inje University Paik Hospital and various other healthcare institutions.
- Offering cancer treatment to patients at more than 2,000 locations worldwide.
- Collaborating with research institutions and business entities to drive progress in precision oncology.
Frequently Asked Questions
Lunit Inc. uses artificial intelligence to create innovative tools for cancer diagnosis and care. Their AI solutions help identify cancer early and forecast how well treatments will work, which can save lives.
Healthcare professionals can incorporate Lunit's AI technology into their current medical imaging systems for cancer screening purposes. This integration enables the precise identification of cancers at an early stage, resulting in timely intervention and higher survival rates. Lunit's AI-powered biomarker can be utilized in cancer treatment to forecast treatment outcomes, thereby enhancing the effectiveness of immunotherapy.
Lunit Inc. uses AI technology to create innovative solutions for cancer diagnosis and care, with the goal of saving lives.
Lunit Inc.'s AI technology is capable of being incorporated into current medical imaging systems, enabling the detection of cancers at an early stage, which facilitates prompt medical intervention and enhances the likelihood of successful treatment outcomes.
Lunit Inc.'s Artificial Intelligence technology successfully identifies biomarkers that accurately forecast how well a patient will respond to treatment, thus enhancing the effectiveness of immunotherapy.
Lunit Inc. carries out extensive research efforts, resulting in more than 200 studies and abstracts that back the creation of their Artificial Intelligence solutions.
Lunit Inc. has key features such as using Artificial Intelligence for identifying cancer, an AI-based biomarker for immunotherapy treatment, a solid research foundation, and globally advanced technology.
Lunit's Artificial Intelligence technology is applicable in daily cancer care practices. It has been implemented in healthcare institutions such as Inje University Paik Hospital. The technology is being used for cancer care in more than 2,000 sites worldwide. Lunit Inc. has also partnered with research and business organizations to advance precision oncology.
